CTN
NIDA-CTN-0134
Identifying Regional “Hotspots” and Potential Correlates of Precipitated Withdrawal During Buprenorphine Induction in Fentanyl Users Through Prescriber Survey Responses and Patient Urine Drug Test Results (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates)
LaTrice Montgomery, Ph.D. , T. John Winhusen, Ph.D.
Jun 03, 2025
CTN
NIDA-CTN-0105
Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders
Li-Tzy Wu, ScD.
May 23, 2025
CTN
NIDA-CTN-0095A1
Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder
Gavin Bart, Ph.D., M.D. , Rebecca Rossom, M.D., M.S.
Apr 22, 2025
CTN
NIDA-CTN-0069
Opioid Use Disorder in the Emergency Department (ED-HEALTH)
David A. Fiellin, M.D. , Gail D'Onofrio, M.D., M.S.
Mar 21, 2025
CTN
NIDA-CTN-0097
Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT)
Adam Bisaga, M.D. , Edward V. Nunes, M.D.
Feb 11, 2025
CTN
NIDA-CTN-0081
Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes (CODE-PRO)
Arjun Krishna Venkatesh, MD, MBA, MHS , Kathryn Hawk, M.D., M.H.S. , Richard Andrew Taylor, MD, MHS
Dec 06, 2024
CTN
NIDA-CTN-0079
Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT)
John Rotrosen, M.D. , Kathryn Hawk, M.D., M.H.S. , Ryan McCormack, M.D.
Nov 04, 2024
CTN
NIDA-CTN-0095A2
Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians
Stephanie Hooker, Ph.D., M.P.H. , Rebecca Rossom, M.D., M.S. , A. Lauren Crain, Ph.D. , Gavin Bart, Ph.D., M.D.
May 24, 2024
CTN
NIDA-CTN-0055
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)
P. Todd Korthuis, MD
Mar 07, 2024
CTN
NIDA-CTN-0051A2
Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051
John Rotrosen, M.D.
Feb 15, 2024
CTN
NIDA-CTN-0067
Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
P. Todd Korthuis, MD
Jul 26, 2023
CTN
NIDA-CTN-0093
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
Gerald Cochran, PhD , T. John Winhusen, Ph.D.
Apr 13, 2023
CTN
NIDA-CTN-0075
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder
Li-Tzy Wu, ScD. , Paolo Mannelli, MD
Feb 16, 2023
CTN
NIDA-CTN-0051
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
John Rotrosen, M.D.
Jan 12, 2018
DTMC
NIDA-CSP-1020
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Ann Montgomery, R.N.
Dec 21, 2017
CTN
NIDA-CTN-0059
The TAPS Tool: Screen and Brief Assessment Tool Validation Study
Robert P Schwartz, M.D. , Li-Tzy Wu, ScD. , Jennifer McNeely, M.D.
Sep 14, 2017
CTN
NIDA-CTN-0030A3
Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence)
Roger Weiss, M.D. , Jennifer Sharpe Potter, Ph.D.
Aug 22, 2014
CTN
NIDA-CTN-0030
A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence
Walter Ling, M.D. , Roger Weiss, M.D.
Jun 22, 2011
CTN
NIDA-CTN-0027
Starting Treatment with Agonist Replacement Therapies (START)
Walter Ling, M.D.
Jun 06, 2012
CTN
NIDA-CTN-0003
Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
Walter Ling, M.D.
May 29, 2008
CTN
NIDA-CTN-0002
Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
Walter Ling, M.D.
Jul 26, 2006
CTN
NIDA-CTN-0001
Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification
Walter Ling, M.D.
May 08, 2006
DTMC
NIDA-CSP-1018
A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Walter Ling, M.D. , Paul J. Fudala, Ph.D. , Paul Casadonte, M.D.
Sep 02, 2015
DTMC
NIDA-CSP-1008B
A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Peter Bridge, M.D.
Dec 04, 2014
DTMC
NIDA-CSP-1008A
A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Peter Bridge, M.D. , Paul J. Fudala, Ph.D.
Dec 04, 2014
DTMC
NIDA-CSP-999
A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence
Walter Ling, M.D. , Donald R. Wesson, M.D. , C. James Klett, Ph.D.
Sep 02, 2015